Cargando…
Challenges and Perspectives for Therapeutic Targeting of Myeloproliferative Neoplasms
Myeloproliferative neoplasms (MPNs) are hematopoietic stem cell disorders with dysregulated myeloid blood cell production and propensity for transformation to acute myeloid leukemia, thrombosis, and bleeding. Acquired mutations in JAK2, MPL, and CALR converge on hyperactivation of Janus kinase 2 (JA...
Autores principales: | Brkic, Sime, Meyer, Sara C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773330/ https://www.ncbi.nlm.nih.gov/pubmed/33403355 http://dx.doi.org/10.1097/HS9.0000000000000516 |
Ejemplares similares
-
Dual targeting of JAK2 and ERK interferes with the myeloproliferative neoplasm clone and enhances therapeutic efficacy
por: Brkic, Sime, et al.
Publicado: (2021) -
Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives
por: Baumeister, Julian, et al.
Publicado: (2021) -
Recent Advances in Molecular Diagnostics and Targeted Therapy of Myeloproliferative Neoplasms
por: Stivala, Simona, et al.
Publicado: (2021) -
Novel therapeutics in myeloproliferative neoplasms
por: Venugopal, Sangeetha, et al.
Publicado: (2020) -
Targeted therapies for myeloproliferative neoplasms
por: Li, Bing, et al.
Publicado: (2019)